122 related articles for article (PubMed ID: 16736159)
1. Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.
Shah DI; Singh M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):221-9. PubMed ID: 16736159
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
Shah DI; Singh M
Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
[TBL] [Abstract][Full Text] [Related]
3. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
Jindal S; Singh M; Balakumar P
Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
[TBL] [Abstract][Full Text] [Related]
4. Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.
Shah DI; Singh M
Fundam Clin Pharmacol; 2006 Dec; 20(6):595-604. PubMed ID: 17109653
[TBL] [Abstract][Full Text] [Related]
5. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction.
Shah DI; Singh M
Can J Physiol Pharmacol; 2006; 84(8-9):835-45. PubMed ID: 17111028
[TBL] [Abstract][Full Text] [Related]
6. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
Balakumar P; Sharma R; Singh M
Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
[TBL] [Abstract][Full Text] [Related]
7. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
Shah DI; Singh M
Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
Shah DI; Singh M
Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
[TBL] [Abstract][Full Text] [Related]
9. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats.
Shah DI; Singh M
Mol Cell Biochem; 2007 Jan; 295(1-2):65-74. PubMed ID: 16841179
[TBL] [Abstract][Full Text] [Related]
10. Activation of protein kinase A improves vascular endothelial dysfunction.
Shah DI; Singh M
Endothelium; 2006; 13(4):267-77. PubMed ID: 16990183
[TBL] [Abstract][Full Text] [Related]
11. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
Kaur T; Goel RK; Balakumar P
Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
[TBL] [Abstract][Full Text] [Related]
12. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
Kaur J; Reddy K; Balakumar P
Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
[TBL] [Abstract][Full Text] [Related]
13. Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Tyagi S; Sharma S; Budhiraja RD
Can J Physiol Pharmacol; 2012 Jul; 90(7):881-5. PubMed ID: 22731503
[TBL] [Abstract][Full Text] [Related]
14. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
Verma S; Reddy K; Balakumar P
Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
[TBL] [Abstract][Full Text] [Related]
15. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
Jyoti U; Kansal SK; Kumar P; Goyal S
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
Chakkarwar VA
Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition.
Sharma S; Singh M; Sharma PL
Vascul Pharmacol; 2011; 54(3-6):80-7. PubMed ID: 21237289
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase inhibitor bis(maltolato)oxovanadium attenuates myocardial reperfusion injury by opening ATP-sensitive potassium channels.
Liem DA; Gho CC; Gho BC; Kazim S; Manintveld OC; Verdouw PD; Duncker DJ
J Pharmacol Exp Ther; 2004 Jun; 309(3):1256-62. PubMed ID: 14993257
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
Kathuria S; Mahadevan N; Balakumar P
Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Nirwane A; Pawar V; Majumdar A
J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]